Pfizer and BioNTech are seeking FDA authorization on the vaccine for 5 to 11-year-olds, and it could come as flu season is in full swing.

from MarketWatch.com - Top Stories https://ift.tt/3iDCBDN
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3iDCBDN
via IFTTT
Kommentare
Kommentar veröffentlichen